Business Description
ArcticZymes Technologies ASA
ISIN : NO0010014632
Total Employee Number:
59Description
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Norway, Germany, France, Italy, UK, Other countries in Europe, and Rest of world.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 13.79 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | 1.11 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 18.28 | |||||
Beneish M-Score | -2.91 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -6.4 | |||||
3-Year EBITDA Growth Rate | -23.6 | |||||
3-Year EPS without NRI Growth Rate | -39.3 | |||||
3-Year FCF Growth Rate | -21.6 | |||||
3-Year Book Growth Rate | 5.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 69.06 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 17.16 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 22.57 | |||||
9-Day RSI | 31.71 | |||||
14-Day RSI | 37.94 | |||||
3-1 Month Momentum % | 6.63 | |||||
6-1 Month Momentum % | -12.92 | |||||
12-1 Month Momentum % | 26.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 15.83 | |||||
Quick Ratio | 15.05 | |||||
Cash Ratio | 13.56 | |||||
Days Inventory | 970.69 | |||||
Days Sales Outstanding | 53.86 | |||||
Days Payable | 304.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | -0.08 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 95.08 | |||||
Operating Margin % | 6.65 | |||||
Net Margin % | 11.59 | |||||
EBITDA Margin % | 14.26 | |||||
FCF Margin % | 19.07 | |||||
OCF Margin % | 21.88 | |||||
ROE % | 4.23 | |||||
ROA % | 3.94 | |||||
ROIC % | 6.03 | |||||
3-Year ROIIC % | -78.49 | |||||
ROC (Joel Greenblatt) % | 12.76 | |||||
ROCE % | 2.38 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 72.89 | |||||
Forward PE Ratio | 52.78 | |||||
PE Ratio without NRI | 72.89 | |||||
Shiller PE Ratio | 64.18 | |||||
Price-to-Owner-Earnings | 124.84 | |||||
PS Ratio | 8.63 | |||||
PB Ratio | 2.84 | |||||
Price-to-Tangible-Book | 3.15 | |||||
Price-to-Free-Cash-Flow | 44.38 | |||||
Price-to-Operating-Cash-Flow | 38.68 | |||||
EV-to-EBIT | 89.69 | |||||
EV-to-Forward-EBIT | 55.61 | |||||
EV-to-EBITDA | 41.86 | |||||
EV-to-Forward-EBITDA | 32.86 | |||||
EV-to-Revenue | 5.97 | |||||
EV-to-Forward-Revenue | 5.16 | |||||
EV-to-FCF | 31.62 | |||||
Price-to-GF-Value | 0.77 | |||||
Price-to-Projected-FCF | 2.06 | |||||
Price-to-Median-PS-Value | 0.88 | |||||
Price-to-Graham-Number | 3.2 | |||||
| Price-to-Net-Current-Asset-Value | 3.54 | |||||
| Price-to-Net-Cash | 4.22 | |||||
Earnings Yield (Greenblatt) % | 1.11 | |||||
FCF Yield % | 2.39 | |||||
Forward Rate of Return (Yacktman) % | -17.7 |
ArcticZymes Technologies ASA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ArcticZymes Technologies ASA Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-05 | In 113 days | ||
| Third quarter earnings results for 2026 | 2026-11-05 | In 113 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-14 | In 30 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 30 days | ||
| General meeting for 2026 | 2026-05-28 12:00 | 19.80 (-0.75%) | ||
| First quarter earnings conference call for 2026 | 2026-05-07 08:30 | 23.90 (+3.02%) | ||
| First quarter earnings results for 2026 | 2026-05-07 07:00 | 23.90 (+3.02%) | ||
| Annual report for 2025 | 2026-04-30 | 21.30 (+6.50%) | ||
| Capital Markets Day | 2026-03-06 09:00 | 23.50 (+2.17%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-12 10:00 | 21.50 (+0.00%) |
Show
Entries
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on ArcticZymes Technologies ASA
No articles.